Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06269913

A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II

Novel Iron-Based Supplement for Active Young Women With Sub-Optimal Iron

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Calgary · Academic / Other
Sex
Female
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study aims to assess the efficacy of a novel iron supplement in improving iron status, gut microbiome, and exercise performance in endurance-trained females.

Detailed description

Current iron supplements on the market are commonly associated with side effects including gastrointestinal distress, nausea, vomiting, and constipation. As a solution, we have developed a novel delivery system for iron supplementation that overcomes many of these limitations. The goal of this study is to assess the efficacy of a yeast-iron complex in improving iron status, gut microbiome, and exercise performance in young, endurance-trained females with sub-optimal iron status. Participants will consume 40mg of elemental iron every second day for 8 weeks. Before and after supplementation,participants will be assessed for exercise capacity (VO2max), iron status, and the current state of the gut microbiome. each week during supplementation, participants will complete a survey in in which they will report feelings of stress and recovery as well as gastrointestinal symptoms.

Conditions

Interventions

TypeNameDescription
OTHERFeSCIron/yeast complex

Timeline

Start date
2024-06-17
Primary completion
2025-03-12
Completion
2025-12-01
First posted
2024-02-21
Last updated
2025-05-30

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06269913. Inclusion in this directory is not an endorsement.